Here are the DEF 14A proxy statements from Electromed, Inc. (ELMD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ELMD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ELMD filings page.
Electromed, Inc. asks shareholders to vote at its virtual annual meeting on November 13, 2026, on four matters: electing seven director nominees and setting the Board at seven, ratifying RSM US LLP for fiscal 2027, advisory approval of executive compensation, and approval of the Employee Stock Purchase Plan. The Board recommends voting FOR each proposal.
The Board approved the proposed ESPP on August 21, 2026, subject to shareholder approval; it would become effective upon approval within 12 months. The plan would reserve 750,000 shares, approximately 9% of the 8,287,085 shares outstanding on September 16, 2026. Its purchase price would be the lesser of 85% of fair market value on the first or last trading day of a purchase period. James L. Cunniff, President and Chief Executive Officer, plans to retire from all company positions on or about April 2, 2027, and the Board is conducting a search for his successor. Fiscal 2026 net income was $11.301 million, compared with $7.537 million in fiscal 2025.